These studies are relevant to patients with CACP syndrome and others with transient loss of PRG4 in inflammatory joint diseases such as traumatic injuries which are known to place a patient at risk for osteoarthritis (OA). This evidence concerns the gene PRG4 and camptodactyly-arthropathy-coxa vara-pericarditis syndrome.